Kiniksa Pharmaceuticals Ltd (KNSA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $43.49
• Market Cap: $3.24B
• P/E Ratio: 95.02
• EPS: $0.45
• 52-Week High: $49.12
• 52-Week Low: $18.25

Market Sentiment

Kiniksa Pharmaceuticals Ltd currently has a Neutral sentiment score of 0.07.

About Kiniksa Pharmaceuticals Ltd

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kiniksa Pharmaceuticals Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KNSA pay dividends?

Kiniksa Pharmaceuticals Ltd (KNSA) does not currently pay a regular dividend.

What is KNSA's P/E ratio?

Kiniksa Pharmaceuticals Ltd has a price-to-earnings (P/E) ratio of 95.02.

What is KNSA's market cap?

Kiniksa Pharmaceuticals Ltd (KNSA) has a market capitalization of $3.24B with a current stock price of $43.49.